Clinical Trial Update: Carbamazepine Extended-Release for the Treatment of Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 trial of carbamazepine extended-release for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Carbamazepine Extended-Release (carbamazepine extended-release)

Snippet

Sponsor: Tuscaloosa Research & Education Advancement Corporation | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED